Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/22061
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGiannakopoulos, X. K.en
dc.contributor.authorGiotis, C.en
dc.contributor.authorKarkabounas, SChen
dc.contributor.authorVerginadis,, IIen
dc.contributor.authorSimos, Y. V.en
dc.contributor.authorPeschos, D.en
dc.contributor.authorEvangelou, A. M.en
dc.date.accessioned2015-11-24T19:20:46Z-
dc.date.available2015-11-24T19:20:46Z-
dc.identifier.issn1573-2584-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/22061-
dc.rightsDefault Licence-
dc.titleEffects of pulsed electromagnetic fields on benign prostate hyperplasiaen
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.primary10.1007/s11255-011-9944-7-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/21537858-
heal.identifier.secondaryhttp://www.springerlink.com/content/h315617342005622/fulltext.pdf-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.publicationDate2011-
heal.abstractINTRODUCTION: Benign prostate hyperplasia (BPH) has been treated with various types of electromagnetic radiation methods such as transurethral needle ablation (TUNA), interstitial laser therapy (ILC), holmium laser resection (HoLRP). In the present study, the effects of a noninvasive method based on the exposure of patients with BPH to a pulsative EM Field at radiofrequencies have been investigated. MATERIALS AND METHODS: Twenty patients with BPH, aging 68-78 years old (y.o), were enrolled in the study. Patients were randomly divided into two groups: the treatment group (10 patients, 74.0 +/- 5.7 y.o) treated with the alpha-blocker Alfusosin, 10 mg/24 h for at least 4 weeks, and the electromagnetic group (10 patients, 73.7 +/- 6.3 y.o) exposed for 2 weeks in a very short wave duration, pulsed electromagnetic field at radiofrequencies generated by an ion magnetic inductor, for 30 min daily, 5 consecutive days per week. Patients of both groups were evaluated before and after drug and EMF treatment by values of total PSA and prostatic PSA fraction, acid phosphate, U/S estimation of prostate volume and urine residue, urodynamic estimation of urine flow rate, and International Prostate Symptom Score (IPSS). RESULTS: There was a statistically significant decrease before and after treatment of IPSS (P < 0.02), U/S prostate volume (P < 0.05), and urine residue (P < 0.05), as well as of mean urine flow rate (P < 0.05) in patients of the electromagnetic group, in contrast to the treatment group who had only improved IPSS (P < 0.05). There was also a significant improvement in clinical symptoms in patients of the electromagnetic group. Follow-up of the patients of this group for one year revealed that results obtained by EMFs treatment are still remaining. CONCLUSION: Pulsed electromagnetic field at radiofrequencies may benefit patients with benign prostate hyperplasia treated by a non-invasive method.en
heal.journalNameInt Urol Nephrolen
heal.journalTypepeer-reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Files in This Item:
File Description SizeFormat 
Giannakopoulos-2011-Effects of pulsed el.pdf318.75 kBAdobe PDFView/Open    Request a copy


This item is licensed under a Creative Commons License Creative Commons